All filters
Abstracts
Serum Lipid Profile In HIV-Infected Patients, Receiving Different Regimens Of ART
N. Matsiyeuskaya Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
The Role Of Direct Antiviral Therapy With Paritaprevir/Ritonavir + Ombitasvir + Dasabuvir On Fibrosis In Patients With Chronic Hepatitis C And Advanced Fibrosis
C. M. Olariu Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Hepatotoxicity Among HIV-Positive Ukrainian Patients Receiving Different Regimens Of ART
A. Kiurdzhyieva Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
COVID-19, Me and Clinical Pharmacology - Dr. Andrea Calcagno
Presented at:
Liverpool Course 2020
Slidesets
DDIs in Acutely Sick Patients - Prof. Saye Khoo
Presented at:
Liverpool Course 2020
Videos
DDIs in Acutely Sick Patients (Video)- Prof. Saye Khoo
Presented at:
Liverpool Course 2020
Meeting
Liverpool Course 2020
16 Sep 2020
Videos
Managing Complex Patients - US | Charles Flexner
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Monica Gandhi
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Sharon Walmsley
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Daniel Kuritzkes
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Michael Kozal
Presented at:
Managing Complex HIV Patients 2020- US Edition
Abstracts
An assessment of the effects of dolutegravir on gene expression and levonorgestrel clearance in human hepatocytes in vitro
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Cobicistat (COBI)-boosted Protease Inhibitors (PIs) plasma and intracellular (IC) pharmacokinetics (PK) in nicotine users
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Glecaprevir/pibrentasvir pharmacokinetics in HCV/HIV patients co-administered with antiretroviral drugs
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The valproic acid – dolutegravir drug-drug interaction is based on displacement of protein binding and unlikely to be clinically relevant
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Valproic acid co-administration is not associated with lower non-dolutegravir antiretrovirals’ exposures
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
High incidence of drug-drug interactions with hepatitis C direct-acting antivirals in patients hospitalized during their treatment
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Effect of tenofovir and bacavir on dolutegravir transport in vitro and in vivo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Review on drug interactions of ART and tuberculosis medications
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Comparison of relative bioavailability of pediatric triumeq and pediatric dolutegravir/lamivudine dispersible tablets to conventional film coated tablets in healthy adults
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019